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Summary
Background: Mammalian DOR was discovered as a gene
whose expression ismisregulated inmuscle of Zucker diabetic
rats. Because noDOR loss-of-functionmammalianmodels are
available, we analyze here the in vivo function of DOR by
studying flies mutant for Drosophila DOR (dDOR).
Results: We show that dDOR is a novel coactivator of ecdy-
sone receptor (EcR) that is needed during metamorphosis.
dDOR binds EcR and is required for maximal EcR transcrip-
tional activity. In the absence of dDOR, flies display a number
of ecdysone loss-of-function phenotypes such as impaired
spiracle eversion, impaired salivary gland degradation, and
pupal lethality. Furthermore, dDOR knockout flies are lean.
We find that dDOR expression is inhibited by insulin signaling
via FOXO.
Conclusion: This work uncovers dDOR as a novel EcR coac-
tivator. It also establishes a mutual antagonistic relationship
between ecdysone and insulin signaling in the fly fat body.
Furthermore, because ecdysone signaling inhibits insulin
signaling in the fat body, this also uncovers a feed-forward
mechanism whereby ecdysone potentiates its own signaling
via dDOR.
Introduction
Thyroid hormone receptor (TR) is an important regulator of
development and metabolism in animals [1, 2]. TR is a type II
nuclear hormone receptor (NR). It resides in the nucleus and
binds DNA regardless of ligand binding, and it heterodimerizes
with retinoid X receptor (RXR) [2]. In the absence of ligand, TR
is complexed with corepressors to inhibit transcription,
whereas in the presence of ligand, it binds coactivators and
activates transcription [2, 3]. One recently discovered TR co-
activator is DOR [4]. DOR was first identified as a gene that
is downregulated in muscle of diabetic rats [4]. DOR was
then shown to have two functions. It acts as a coactivator of
thyroid hormone receptor TRa1, binding TRa1 and impacting
its transcriptional activity [4]. Furthermore, DOR has a second
life outside the nucleus, as a regulator of autophagy [5, 6].
Together, these data implicate DOR as a regulator of NR*Correspondence: antonio.zorzano@irbbarcelona.org (A.Z.), a.teleman@
dkfz.de (A.A.T.)function and of metabolism. However, no DORmutant animals
have yet been reported, and the in vivo function of DOR
remains to be studied.
We study here the Drosophila homolog of DOR. Drosophila
has 18 nuclear receptors, including ecdysone receptor (EcR).
EcR sharesmany commonalities with type II NRs, in that it het-
erodimerizes with the fly RXR homolog USP, binds DNA
constitutively, complexeswith either coactivators or corepres-
sors depending on its state of ligand binding, and can form
a functional complex with mammalian RXR [1, 7–10]. The
EcR/USP complex senses and responds to the hormone
20-hydroxyecdysone (20E) to regulate developmental timing
and metabolism. 20E triggers all developmental transitions,
such as the molts from one larval stage to the next, and
many events occurring during metamorphosis. These include
termination of larval feeding, apoptosis, and elimination of
larval salivary glands and larval fat body, as well as many
morphological changes in tissues that will give rise to the adult
fly [1, 7, 8]. Several EcR corepressors and coactivators have
been identified and characterized, including Alien [11],
SMRTER [12], bonus [13], Trithorax-related gene (TRR) [14],
Taiman [15], and rigor mortis [16]. However the coactivator(s)
of EcR required for proper pupal development and metamor-
phosis remain to be described.
Interestingly, crosstalk has recently come to light between
ecdysone signaling and insulin signaling, which regulates the
growth and metabolism of animals [17]. Ecdysone regulates
insulin signaling and vice versa [18–20]. In particular, in the
fat body of the fly, ecdysone signaling inhibits PI3K activity
and thereby insulin signaling, suggesting an antagonistic rela-
tionship between these two hormonal signaling pathways
[18, 21–24]. Themolecular mechanisms underlying these regu-
latory events, however, are not fully understood.
Results
dDOR Encodes the Drosophila Homolog
of Mammalian DOR
In order to study the function of DOR in an in vivo animal
model, we searched the Drosophila genome for homologs of
human DOR (hDOR). A BLAST search through all predicted
Drosophila proteins with the sequence of hDOR yielded
CG11347 as the top hit, which we rename Drosophila DOR
(dDOR) (Figure S1, available online).
The dDOR locus is predicted to encode six different tran-
scripts, giving rise to three different polypeptides (Figure 1A)
[25]. The -RA, -RB, -RD, and -RE isoforms encode a 387 amino
acid protein hereafter referred to as DORlong, whereas the -RC
isoform encodes a shorter protein, of 273 amino acids, which
we refer to as DORshort (Figures 1A and 1C). The -RF isoform
encodes an even shorter protein similar to DORshort but lacking
44 amino acids at the N terminus. While performing RT-PCR
with oligonucleotides specific for the long isoform, we noticed
the presence of two differently sized PCR products.
Sequencing revealed that one of the products corresponded
to the predicted ‘‘long’’ isoform. The second product corre-
sponded to an unannotated isoform consisting of the ‘‘long’’
isoform plus a 90 bp extension of the third exon, resulting
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Figure 1. dDOR Gene Structure and Splice Isoforms
(A) Overview of the dDOR (CG11347) genomic region. dDOR
codes for six splice variants (-RA to -RF) plus an additional,
previously unannotated splice variant that we term
dDORFENLL, containing an extended third exon. The
knockout region, as indicated, encompasses the entire
open reading frame of all isoforms.
(B) Additional nucleotide and amino acid sequence present
in the splice variant with an extended third exon (dDORFENLL
isoform). This splice form encodes a protein containing
a motif (in bold) similar to the LXXLL motif found in nuclear
receptor cofactors.
(C) Schematic representation of the three dDOR protein iso-
forms: FENLL, long (RA, RB, RD, and RE), and short (RC).
NLS denotes nuclear localization signal.
(D) mRNA expression levels of the three dDOR isoforms in
the whole animal during development, measured by quanti-
tative RT-PCR normalized to rp49.
(E) mRNA expression levels of the three dDOR isoforms in fat
bodies of wandering third-instar larvae and pupae,measured
by quantitative RT-PCR normalized to rp49.
Error bars represent standard error of the mean (SEM).
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1800from use of an alternate splice donor (Figures 1A and 1B). As a
result, 30 amino acids are inserted in the middle of the
dDORlong protein. Contained in these 30 amino acids is the
sequence FENLL (Figure 1B in bold), which is similar to
the LXXLL nuclear-receptor-interacting motif found in nuclear
receptor coactivators [3, 26]. This FENLL sequence aligns to
the transactivation domain motif of human DOR (LEDLL)
when the two proteins are aligned to each other (Figure S1 in
bold). We refer to this isoform as dDORFENLL. The domain of
dDORFENLL surrounding the FENLL sequence has 75% identity
and 85% homology to human DOR (Figure S1). The three
isoforms of dDOR that we study in thismanuscript are summa-
rized schematically in Figure 1C.
In order to measure the relative abundance of the three
isoforms in vivo, we performed quantitative RT-PCR with
isoform-specific primers on RNA extracted from animals of
various stages of development (Figure 1D). The most abun-
dant isoform is the long one, followed by the FENLL isoform
(roughly half the level of the long isoform), whereas the short
isoform is expressed at comparatively low levels (Figure 1D).
This relative expression of the three isoforms is also observed
in fat body of wandering third-instar larvae whereas in fat bodyof early pupae the FENLL isoform strongly
predominates (Figure 1E). Indeed, the FENLL
isoform is highly enriched in fat body of early
pupae when compared to the rest of the body
(***t test < 0.0001, Figure S1B).
dDOR Knockout Flies Display Defects during
Metamorphosis
In order to study dDOR function in vivo, we
generated dDOR knockout flies by targeted
homologous recombination, replacing the entire
open reading frame of all the splice variants with
the mini-white gene (Figure 1A) [27]. We back-
crossed female flies heterozygous for the dDOR
knockout to w1118 flies for four generations in
order to obtain two fly stocks with similar genetic
backgrounds, differing only by the presence or
absence of the dDOR mutation. The resulting
stocks will be referred to as dDOR knockout flies
and control flies, respectively, and were used forall experiments described here. dDOR knockout flies had no
detectable expression of dDOR mRNA as measured by quan-
titative RT-PCR (Figure 2A) or of dDOR protein (Figure 2B).
dDOR knockout larvae are viable, have no obvious defects,
and pupate at almost the same time as control larvae
(Figure 2C). A number of defects, however, become apparent
duringmetamorphosis. The viability of dDOR knockouts drops
significantly during metamorphosis, so that only 59% of
animals eclose as adults, compared to 91% of controls
(*t test = 0.02, Figure 2D). This viability defect, as well as other
defects mentioned here, is rescued by expression of dDOR
from a UAS transgene, showing that it is specific for dDOR
loss of function. This will be discussed in more detail below.
dDOR knockout animals also display defects in major ecdy-
sone-triggered biological responses. dDOR knockouts have
impaired anterior spiracle eversion, with 35% of dDOR
knockout pupae displaying this phenotype (n = 53), compared
to just 2% of control pupae (n = 51) (Figure 2E). This defect is
not due to the mild delay in pupation of dDOR mutants,
because the 35% of animals that do not evert their spiracles
at pupation still display the same phenotype 48 hr after pupa-
tion and eventually die. Furthermore, destruction of larval
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Figure 2. dDOR Knockout Flies Have Reduced Viability, Pupation Defects,
and Impaired Ecdysone Signaling
(A and B) dDOR knockout animals have no detectable dDOR mRNA or
protein.
(A) mRNA levels of all dDOR splice isoforms in wandering third-instar larvae
measured by quantitative RT-PCR, normalized to rp49. Error bars represent
SEM. *** t test = 0.001.
(B) Protein extracts from control and dDOR knockout wandering third-instar
larvae probed with anti-dDOR and anti-tubulin antibody.
(C) dDOR knockout animals are not strongly delayed in development. Pupa-
tion curves show the percentage of pupated animals as a function of time
after egg laying (AEL) for control animals (gray curve, n = 82) and dDOR
knockout animals (black curve, n = 78). Error bars represent SEM.
(D) dDOR knockout flies have reduced viability. The percentage of live
adults relative to collected first-instar larvae for animals of indicated geno-
types is shown. Error bars represent SEM. * t test = 0.02.
(E) Representative images of defective anterior spiracle eversion, observed
in 35% of dDOR knockout pupae.
(F) Larval salivary gland death duringmetamorphosis, observed via salivary-
gland-specific GFP expression in control and dDOR knockout pupae, 12 hr
and 24 hr after puparium formation (APF). Sixty-six percent of dDOR
mutants display delayed degradation of salivary glands, as observed by
residual GFP 24 hr APF.
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1801salivary glands is impaired in dDOR knockouts. Using flies ex-
pressing GFP in the larval salivary glands (esg-GAL4, UAS-
GFP), we followed the fate of the salivary glands in vivo during
metamorphosis. Whereas larval salivary glands were
completely removed in wild-type animals by 24 hr after pupa-
tion, 66% of dDOR knockouts still had visible GFP at this time
(Figure 2F).dDOR Knockouts Have Impaired Ecdysone Signaling
Human DOR functions as a transcriptional coactivator of the
TRa1 thyroid hormone nuclear receptor, which shares some
properties with the Drosophila ecdysone receptor. Further-
more, ecdysone plays a fundamental role during metamor-
phosis, regulating for instance spiracle eversion and salivary
gland degradation. Therefore, we asked whether dDOR
mutants have defects in ecdysone signaling. At the end of
larval third instar, a pulse of ecdysone induces larvae to
wander out of their food and to begin pupating [1]. This corre-
lates with induction of several direct transcriptional targets of
the ecdysone receptor including Eip75B and the broad
complex (BR-C) [1]. We performed a time-course analysis of
gene expression in carefully staged animals, from 24 hr prior
to pupation to 12 hr after pupation, measuring mRNA levels
of Eip75B isoform A (E75A) and BR-C by quantitative RT-PCR
(Figure S2). As expected fromprevious studies [28], bothBR-C
andE75A expression increased dramatically in control animals
during the ‘‘wandering’’ stage, 0–6 hr prior to pupation (Figures
S2A and 2B, black lines). In contrast, induction of both genes
was severely blunted in dDOR knockouts (Figures S2A and
2B, gray lines). A similar defect in induction of EcR target
gene expression could be observed when measuring all
Eip75B isoforms combined (E75) (Figure S2C) or another direct
EcR target gene, E74 (Figure S2D). In contrast, two genes that
are not direct ‘‘early response’’ genes of ecdysone signaling,
bFTZ-F1 and DHR3, were less affected (Figures S2E and
S2F). To quantify the induction of E75 and BR-C in response
to the ecdysone pulse that causes larvae to wander out of
the food, we focused on two time points: ‘‘feeding’’ animals
24 hr prior to pupation (before the ecdysone pulse) versus
‘‘wandering’’ animals 0–6 hr prior to pupation (after the ecdy-
sone pulse). In control animals, expression of E75 and BR-C
was upregulated roughly 20-fold in wandering animals
compared to feeding animals (Figure 3A). In contrast, in
dDOR knockout animals, induction of both EcR targets was
significantly impaired (**t test < 0.001, Figure 3A).
To test whether dDORmutant tissue has an impaired ability
to sense and respond to ecdysone hormone, we explanted fat
bodies from control and dDOR knockout animals, treated
them with exogenously supplied ecdysone (1 mM 20-hydrox-
yecdysone, 20E) for 4 hr, and then measured induction of
E75 and BR-C by quantitative RT-PCR. Expression of both
E75 and BR-C was strongly induced in fat body explants
from control animals upon ecdysone treatment (Figure 3B,
white bars). In comparison, induction of E75 and BR-C was
impaired in fat body explants from dDOR knockouts
(*t test = 0.01; **t test = 0.003; Figure 3B, black bars), indi-
cating that intracellular ecdysone signaling is defective in
dDOR mutant tissue. We also asked whether dDOR is
required for effective ecdysone signaling in Kc167 cells, which
are known to be ecdysone responsive [29, 30]. When Kc cells
were treated with 20E (1 mM) for 12 hr, expression of both E75
and BR-C was strongly induced (Figure 3C, white bars). In
comparison, induction of E75 and BR-C was significantly
blunted in Kc cells in which dDOR expression had been
knocked down by dsRNA treatment (t test = 0.001 and 0.01,
respectively, Figure 3C, black bars). To test whether the
defect in E75 and BR-C induction is due specifically to
reduced function of the ecdysone receptor complex, we
made use of a luciferase reporter containing tandem repeats
of the ecdysone receptor response element (EcRE) [30]. Kc
cells transfected with the EcRE reporter had markedly
increased luciferase activity upon treatment with 20E
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Figure 3. dDORBinds Physically to EcR and Potentiates EcR
Transcriptional Activation
(A) dDOR knockout animals have impaired ecdysone
signaling. Fold induction in expression of two direct target
genes of ecdysone receptor, broad (‘‘BR-C,’’ black bars)
and Eip75B (all isoforms, ‘‘E75,’’ white bars). Induction is
measured in wandering third-instar larvae (0–6 hr prior to
pupation) compared to feeding third-instar larvae (24 hr prior
to pupation), by quantitative RT-PCR relative to rp49, for
animals of indicated genotypes. Error bars represent SEM.
**t test < 0.001.
(B) dDORmutant tissue is impaired in its response to exoge-
nously applied ecdysone. Fat body explants from control and
dDOR knockout wandering L3 larvae were cultured in
Grace’s insect medium in the presence or absence of 20-hy-
droxyecdysone (20E) (1 mM for 4 hr), and expression of the
EcR target genes E75 (top panel) and BR-C (bottom panel)
was measured by quantitative RT-PCR relative to rp49. Error
bars represent SEM. *t test = 0.01; **t test = 0.003.
(C) Knockdown of dDOR in Kc167 cells causes an impaired
transcriptional response to ecdysone. Kc cells treated with
control dsRNA or dsRNA against dDOR were cultured in
the presence or absence of 20E (1 mM, 12 hr), and expression
of the EcR target genes E75 (top panel) and BR-C (bottom
panel) was measured by quantitative RT-PCR relative to
rp49. Treatment of Kc cells with dsRNA against dDOR
reduced dDOR expression at the RNA level by 58%,
measured by quantitative RT-PCR (not shown). Error bars
represent SEM. **t test = 0.01; *** t test = 0.001.
(D) Knockdown of dDOR in Kc167 cells impairs induction of
an ecdysone-receptor-responsive reporter. Kc167 cells,
transfected with an EcRE-dependent firefly luciferase
reporter, together with a constitutive renilla luciferase
construct for normalization, were stimulated with 20E
(10 mM) for 12 hr. Relative firefly/renilla luciferase activity is
indicated. Error bars represent SEM. *t test = 0.02.
(E) EcR interacts physically with the FENLL isoform of dDOR,
but not the short or long isoforms of dDOR lacking the
LXXLL-like motif. S2 cells were transfected with constructs
for expression of EcR (RB isoform), USP, and various iso-
forms of dDOR, as indicated, and were treated with 10 mM
20E for 12 hr. Immunoprecipitation of the various dDOR iso-
forms was performed with anti-FLAG antibody. Lysates and
IPs were probed with anti-EcR and anti-dDOR antibodies.
(F) dDORFENLL interacts specifically with EcR. GST-tagged
Drosophila nuclear receptors (EcR, USP, DHR3, FTZf1a,
and FTZf1b) were expressed in bacteria and purified with
Gluthathione-S-sepharose beads. Beads containing equal
amounts of the various recombinant nuclear receptors
were incubated with lysates of S2 cells expressing
dDORFENLL. S2 lysates and GST pull-downs were probed
with anti-dDOR antibody.
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1802(Figure 3D, white bars). This induction was significantly
impaired when cells were treated with dsRNA against dDOR
(*t test = 0.02, Figure 3D, black bars), indicating that depletion
of dDOR blunts the ability of EcR to activate transcription via
EcR response elements.
The FENLL Isoform of dDOR, but Not the Other Isoforms
of dDOR, Binds EcR
The data presented above indicate that dDOR is required for
the ecdysone receptor complex to function properly. Because
dDOR has a nuclear hormone coactivator-like motif, we tested
whether dDOR binds physically to EcR. We expressed FLAG-
tagged versions of the three dDOR isoforms (FENLL, long, and
short) together with EcR and its partner USP in S2 cells and
precipitated dDOR with anti-FLAG antibody. Although we
could not detect EcR in the immunoprecipitates of dDORshort
or dDORlong (Figure 3E, lanes 6 and 7), we could readily detectEcR in the immunoprecipitate of the FENLL form of dDOR
(Figure 3E, lane 5). The fact that EcR coimmunoprecipitates
only with dDORFENLL but not the other two isoforms of dDOR
highlights the specificity of this interaction. Particularly striking
is the comparison between the dDORFENLL and dDORlong
immunoprecipitates, because the two proteins differ by only
30 amino acids containing the FENLL motif. Specific mutation
of the amino acids FENLL to AENAA reduced binding of the
FENLL isoform to EcR by 59% (Figure S2H).
In order to test the specificity of binding of dDOR to EcR, we
performed a GST-pull-down assay with a panel of recombi-
nantly expressed Drosophila nuclear receptors (EcR, USP,
DHR3, FTZf1a, and FTZf1b) (Figure 3F). Whereas beads con-
taining GST-EcR readily coimmunoprecipitated dDOR from
lysates of S2 cells expressing dDOR-FENLL, beads containing
equal amounts of the other nuclear receptors did not
(Figure 3F and Figure S2I).
BR-C
E75
co
ntr
ol
DO
R-
/-
UA
S-d
DO
Rl
on
g; 
DO
R-
/-
UA
S-d
DO
RF
EN
LL
; D
OR
-/-
tub
G4
; D
OR
-/-
tub
G4
>U
AS
-dD
OR
lon
g; 
DO
R-
/-
tub
G4
>U
AS
-dD
OR
FE
NL
L; 
DO
R-
/-
genotype:   control     control     DOR-/-    DOR-/-
        20E:        -               +              -               +
***
**
*
tub
G4
>U
AS
-dD
OR
FE
NL
L; 
DO
R-
/-
tub
G4
>U
AS
-dD
OR
lon
g; 
DO
R-
/-
tub
G4
; D
OR
-/-
UA
S-d
DO
RF
EN
LL
; D
OR
-/-
UA
S-d
DO
Rl
on
g; 
DO
R-
/-
DO
R-
/-
co
ntr
ol
A
B
C
**
***
Figure 4. Rescue of dDORMutant Phenotypes by Isoform-Specific Expres-
sion of dDOR
(A) Impaired ecdysone signaling in dDOR knockout animals is rescued
specifically by the dDORFENLL isoform. Fold induction in expression of two
direct target genes of ecdysone receptor, broad (‘‘BR-C,’’ black bars) and
Eip75B (‘‘E75,’’ white bars). Induction is measured in wandering third-instar
larvae (0–6 hr prior to pupation) compared to feeding third-instar larvae
(24 hr prior to pupation), by quantitative RT-PCR relative to rp49, for animals
of indicated genotypes. Error bars represent SEM. **t test < 0.001;
*** t test < 0.0001.
(B) Reduced viability of dDOR knockout flies is rescued specifically by the
dDORFENLL isoform. The percentage of live adults relative to collected
first-instar larvae for animals of indicated genotypes is shown. Error bars
represent SEM. *t test = 0.03; **t test = 0.02.
(C) Ecdysone feeding rescues the viability of dDOR knockout animals. The
percentage of live adults relative to collected first-instar larvae for control
and dDOR knockout animals either fed 0.5 mg/ml 20E or not, as indicated,
is shown. Error bars represent SEM. ***t test = 0.0003.
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1803Wepreviously reported that humanDORhas a dual function,
being involved both in transcriptional coactivation in the
nucleus and in regulation of autophagy in the cytoplasm by
binding to the human autophagy protein Atg8/GATE16 [5].
Therefore, we tested whether dDOR can bind the Drosophila
homologs of Atg8, Atg8a, and Atg8b. We expressed the three
dDOR isoforms (FENLL, long, and short) together with
HA-tagged Atg8a and Atg8b in S2 cells and immunoprecipi-
tated the Atg proteins via their HA tags. Both the FENLL and
long isoforms of dDOR bound the Atg proteins, but the short
isoform of dDOR did not (Figure S3). This indicates that the
FENLL-containing domain of dDOR is not required for binding
to the Atgs, whereas it is required for binding to EcR. This also
suggests that the long isoform of DOR, which binds the Atg
proteins but not EcR, might be dedicated to regulating
autophagy.
Ecdysone Receptor Binding by dDOR Is Required
for Proper Ecdysone Signaling and Animal Viability
The differential ability of dDORFENLL and dDORlong to bind
to the ecdysone receptor allowed us to test which defects of
the dDOR knockout animals occur as a consequence of defec-
tive ecdysone signaling. We generated animals homozygous
for thedDOR knockoutmutation inwhich either thedDORFENLL
or the dDORlong isoforms were ubiquitously expressed by
using a UAS transgene together with the tubulin-GAL4 driver.
This essentially generates animals in which dDOR expression
is replaced with expression of only one specific dDOR splice
isoform. As negative controls, we also generated flies homozy-
gous for the dDOR knockout mutation carrying either of the
UAS constructs alone (which by themselves do not express)
or only the Tubulin-GAL4 driver. Unlike dDOR knockouts,
dDOR homozygous knockout animals expressing dDORFENLL
were able to properly upregulate expression of the EcR target
genes E75 and BR-C during the wandering third-instar stage
(***t test < 0.0001, Figure 4A, columns 13 and 14). In contrast,
the dDORlong isoform was unable to rescue induction of these
EcR target genes (Figure 4A, columns 11 and 12). This is in
agreement with our coimmunoprecipitation results showing
that the FENLL isoform binds EcR whereas the long isoform
does not (Figure 3E), and it indicates that binding of dDOR to
EcR is required for proper ecdysone signaling in Drosophila.
Expression of dDORFENLL also rescued the viability defects
of dDOR knockouts (*t test = 0.03, Figure 4B, column 7)
whereas dDORlong did not (Figure 4B, column 6), demon-
strating that the mortality of dDOR knockouts during meta-
morphosis is due to impaired ecdysone signaling. We noted
that in explanted fat bodies from dDOR knockouts, induction
of EcR target genes in response to exogenously applied 20E
was blunted, but not completely abrogated (Figure 3B). This
indicates that although dDOR plays an important role in poten-
tiating the transcriptional activity of the EcR complex, EcR is
still able to weakly induce target gene expression in the
absence of dDOR. This raised the possibility that feeding
20E to dDOR knockouts might compensate for the blunted
activity of EcR in these flies, thereby rescuing their lethality.
Indeed, feeding 20E to dDOR knockout animals was able to
significantly rescue their viability defect (***t test = 0.0003,
Figure 4C).
dDOR-Mediated Regulation of Ecdysone Signaling
Is Required for Proper Animal Metabolism
Expression of DOR in rats was reported to be aberrant upon
development of diabetes [4]. Either this occurs as
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Figure 5. dDOR Knockout Flies Are Lean
(A) dDOR knockout flies are lean. This phenotype
is rescued specifically by the dDORFENLL isoform.
Relative triglyceride levels, normalized to total
body protein, for 1-day old adult flies of indicated
genotypes, were measured. Error bars represent
SEM. *t test = 0.015; ***t test = 0.0004.
(B) dDOR knockout flies have increased
glycogen. Relative glycogen levels, normalized
to total body protein, for 1-day-old control and
knockout adult flies, were measured. Error bars
represent SEM. **t test = 0.001.
(C) dDOR knockout flies have increased trehalose
levels. Error bars represent SEM. *t test = 0.04.
(D) ecd[1] mutants have reduced total body
triglycerides at semirestrictive temperature.
Control and ecd[1] homozygous larvae were
grown at 18C and then shifted to 28C at the
wandering third-instar stage (black bars) or reared
continuously at 18C (gray bars). Relative triglyc-
eride levels, normalized to total body protein, of
the resulting 1-day old adults were measured.
Error bars represent SEM. *t test = 0.03.
(E) Flies expressing a dominant-negative version
of EcR have reduced total body triglycerides.
Flies carrying either heat shock-GAL4 alone
(hs > > +) or heat shock-GAL4 with UAS-EcR
[W650A] (hs > > EcR-DN) were heat shocked (25
min, 38C) at wandering third-instar stage to
induce expression. Relative triglyceride levels,
normalized to total body protein, of the resulting
1-day old adults were measured. Error bars
represent SEM. *t test = 0.01.
(F) EcR-B2-overexpressing flies are fat. Larvae
carrying a transgene for heat-shock-inducible
EcR expression (hs-EcR-B2) were grown at
25C and either not heat shocked (‘‘hs-’’) or heat
shocked during feeding and wandering third-
instar larval stages (37C, 450) to induce EcR-B2
expression (‘‘hs+’’). Relative triglyceride levels,
normalized to total body protein, for resulting
1-day-old adults were measured. Error bars
represent SEM. *t test = 0.04.
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1804a consequence of the diabetes, or it plays a causative role in
development of the disease. To distinguish these two possibil-
ities, animals lacking DOR activity need to be analyzed to test
whether modulation of DOR activity leads to metabolic conse-
quences. With this in mind, we asked whether dDOR knockout
flies have metabolic defects. We measured total body triglyc-
erides, normalized to total body protein, and found that dDOR
knockouts are lean, containing 25% less fat than controls
(*t test = 0.015, Figure 5A). dDOR knockouts also had signifi-
cantly increased glycogen stores (**t test = 0.001, Figure 5B)
and circulating trehalose levels (*t test = 0.04, Figure 5C)
compared to controls, indicating that dDOR regulates meta-
bolic balance. Focusing on the triglyceride phenotype, we
found that it was rescued by expression of dDORFENLL, but
not of dDORlong (***t test = 0.0004, Figure 5A, columns 6 and
7), indicating that the leanness of dDOR mutants results from
impaired ecdysone signaling.
In order to test the metabolic consequences of modulating
ecdysone signaling during pupal development, we performed
three experiments. First, to reduce ecdysone signaling during
pupal development, we employed the widely used ecdysone-
less[1] mutation (ecd[1]), which is a temperature-sensitive
mutation that disrupts ecdysone production at the restrictive
temperature of 29C [31]. We reared control and ecd[1]mutantanimals at permissive temperature (18C) until they started
wandering and then shifted the animals to the semirestrictive
temperature of 28C . This allowed animals to survive to adult-
hood but reduced their ecdysone signaling, as could be ascer-
tained by reduced levels of the EcR target genesBR-C and E75
in the ecd[1] mutants (Figure S4A). At 1 day of adult age, we
measured the fat of these ecd[1] and control animals and
found that ecd[1] animals were 46% leaner than their controls
(*t test = 0.03, Figure 5D, black bars). In contrast, ecd[1] and
control animals reared continuously at permissive tempera-
ture had no significant difference in fat levels (Figure 5D,
gray bars). This suggests that reduced ecdysone signaling
during pupal development leads to leaner adults, similar to
what we observe in dDOR knockouts. As a second approach
to decreasing ecdysone signaling, we created flies carrying
a heat-shock-inducible dominant-negative EcR construct
(heat shock-GAL4, UAS-EcR[W650A]) (‘‘hs > > EcR-DN’’).
These animals, as well as control animals carrying only heat
shock-GAL4 (‘‘hs > > +’’), were heat shocked at wandering
L3 (25 min, 38C). These heat-shock conditions allowed
hs > > EcR-DN animals to survive to adulthood but reduced
their ecdysone signaling, as could be ascertained by reduced
levels of the EcR target genes BR-C and E75 4 hr after heat
shock (Figure S4B). At 1 day of adult age, we measured the
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Figure 6. dDORFENLL Expression Is Regulated
Directly by FOXO, Forming a Feed-Forward
Regulatory Loop between Insulin and Ecdysone
Signaling
(A and A0) dDORFENLL expression is upregulated
in a FOXO-dependent manner upon nutrient with-
drawal in fat body of third-instar larvae. Control
(white bars) or FOXO mutant larvae (black bars)
were either fed or deprived of food for 18 hr.
Expression of dDORFENLL (A) and 4E-BP (a direct
FOXO target, A0) in adipose tissue was measured
by quantitative RT-PCR, normalized to rp49. Fold
induction of expression in starved relative to fed
larvae is indicated. Error bars represent SEM.
**t test < 0.01.
(B and B0) Insulin signaling represses dDOR-
FENLL expression in fat bodies. dDORFENLL (B)
and 4E-BP (B0) mRNA levels in wandering third-
instar larvae fat bodies treated in the presence
or absence of 5 mg/ml insulin for 4 hr in Grace’s
insect medium were measured by quantitative
RT-PCR relative to rp49. Error bars represent
SEM. *t test < 0.03.
(C and C0) dDORFENLL and 4EBP expression
increase in fat body explants treated with ecdy-
sone. Fat bodies of third-instar larvae were
cultured in Grace’s insect medium in the pres-
ence or absence of 20E (10 ug/ml for 4 hr), and
expression of dDORFENLL (C) and 4E-BP (C
0)
was measured by quantitative RT-PCR relative
to rp49. Note the different y axis scale in (D) and
(D0) versus (C) and (C0). Error bars represent
SEM. **t test < 0.01.
(D and D0) dDORFENLL and 4EBP expression do
not increase in fat body explants of FOXO
mutants treated with ecdysone. Fat bodies of
third-instar-larvae FOXO21/25mutants were treated as in (C), and expression of dDORFENLL (D) and 4E-BP (D
0) wasmeasured by quantitative RT-PCR relative
to rp49. Error bars represent SEM.
(E) FOXO binds the dDOR promoter. Quantification by qPCR of genomic DNA in ChIP material from wild-type animals with preimmune serum (‘‘mock,’’
a negative control), from FOXO mutant animals with anti-FOXO antibody (‘‘dFOXO2/2,’’ a negative control), and from wild-type animals with anti-dFOXO
antibody (‘‘dFOXO wt’’). Promoter regions assayed were those of 4E-BP (a direct FOXO target, black bars), mir-278 (negative control, white bars), and
dDOR (gray bars).
(F) Schematic representation of the feed-forward regulatory mechanism comprising ecdysone signaling, insulin signaling, and dDORFENLL. In the fat body,
ecdysone signaling blocks insulin signaling, thereby activating FOXO. FOXO then induces expression of dDORFENLL, which potentiates ecdysone receptor
signaling.
(G) dDORFENLL expression is induced from feeding to wandering third-instar larvae. dDORFENLL mRNA levels measured by quantitative RT-PCR relative to
rp49 for feeding (‘‘fL3’’) and wandering (‘‘wL3’’) third-instar larvae. Error bars represent SEM. ***t test < 0.0001.
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1805fat of hs > > EcR-DN and control animals and found that hs > >
EcR-DN animals were 45% leaner than controls (*t test = 0.01,
Figure 5E), consistent with the results obtained with ecd[1]
animals. Finally, as a third complementary approach, we
increased ecdysone signaling during pupal development to
test the effect on animal metabolism. Flies with heat-shock-
inducible expression of the ecdysone receptor (hs-EcR-B2)
were heat shocked at the end of larval development and
compared to animals of the same genotype that were not
heat shocked. We first tested whether EcR induction
increased ecdysone signaling by measuring mRNA levels of
BR-C and E75 in the resulting 1-day-old adults, and we found
that they were indeed elevated relative to uninduced animals
(Figure S4C). We then measured triglyceride levels in the re-
sulting 1-day-old adults and found that animals with increased
ecdysone signaling were almost twice as fat as the uninduced
animals (*t test = 0.04, Figure 5F). In sum, both the ecdysone
gain-of-function and loss-of-function experiments indicate
that ecdysone signaling promotes adiposity during pupal
development. This is in agreement with the differential ability
of dDORFENLL and dDORlong to rescue the leanness of dDOR
knockout animals (Figure 5A), considering that dDORFENLLpotentiates EcR signaling but dDORlong does not (Figure 4A).
Nonetheless, it is possible that dDORFENLL rescues the lean-
ness of dDOR knockouts by interacting with other unknown
factors.
dDOR Is a Direct Target of the FOXO Transcription Factor
Because expression of human DOR is misregulated, via an
unknown mechanism, in rats upon development of diabetes,
we asked whether expression of Drosophila DOR is also regu-
lated by nutritional conditions. Given that the FENLL isoform of
dDOR is responsible for the metabolic defects of dDOR
mutants (Figure 5A), we focused our attention on the FENLL
isoform. We either fasted or fed third-instar larvae for 18 hr
and then assayed dDORFENLL mRNA levels in fat body by
quantitative RT-PCR. When control larvae were fasted,
dDORFENLL expression in fat body increased > 2-fold
(Figure 6A, white bar). One important signaling pathway that
is inhibited upon fasting is insulin [32]. We therefore asked
whether dDORFENLL expression is inhibited by insulin, because
this would explain its upregulation upon fasting. We treated
explanted fat bodies in the presence or absence of 5 mg/ml
insulin and assayed dDORFENLL expression levels by
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1806quantitative RT-PCR. In the presence of insulin, dDORFENLL
expression decreased by 73% (*t test = 0.03, Figure 6B).
dDORFENLL expression levels also decreased by 59% in S2
cells treated with 1 mM insulin for 2 hr (**t test = 0.006,
Figure S5A).
One transcription factor mediating much of the transcrip-
tional output of the insulin pathway is FOXO [32, 33]. FOXO
activity is suppressed by insulin signaling [34]. We tested
whether regulation of dDORFENLL expression is mediated by
FOXO by studying animals containing the FOXO21/25 null allele
combination. We starved FOXO21/25 mutants and found that
the fasting-induced upregulation of dDORFENLL expression in
fat body was strongly impaired (**t test = 0.005, Figure 6A,
black bar), indicating that this transcriptional regulation is
FOXO dependent. The transcriptional regulation of dDORFENLL
is analogous to that of a canonical FOXO target gene, 4E-BP.
4E-BP expression is suppressed by insulin in vivo in fat bodies
(*t test = 0.01. Figure 6B0) and in S2 cells (**t test = 0.006,
Figure S6A0) and increases in vivo in fat body upon fasting of
wild-type animals (Figure 6A0, white bar) but does not increase
upon fasting of FOXO mutant animals (**t test = 0.006,
Figure 6A0, black bar). We therefore asked whether dDOR is
also a direct transcriptional target of FOXO. In Drosophila,
FOXO targets sites are preferentially located within 1 kb of
the target promoter [32]. We screened the dDOR promoter
region and found a perfect consensus FOXO binding site
(GTAAACAA) 230 nt upstream of the transcription start site
of the –RA and –RB transcripts. To test whether FOXO binds
this site in vivo, we performed chromatin immunoprecipitation
(ChIP) of endogenous FOXO from third-instar larvae. We per-
formed two negative controls: a mock ChIP using preimmune
serum from wild-type animals, and a ChIP using anti-FOXO
antibody [35] from FOXO21/25 null mutant animals (Figure 6E)
[36]. Quantitative PCR (qPCR) on the immunoprecipitated
material revealed that the promoter region of 4E-BP, an estab-
lished direct target of FOXO [35, 37], was strongly enriched in
the FOXO ChIP from wild-type animals, but not in the negative
controls (Figure 6E, black bars). Strikingly, the promoter region
of dDOR-RA/B was also strongly enriched in the FOXO ChIP
(Figure 6E, gray bars) but not in the negative controls,
indicating that FOXO binds the dDOR promoter in vivo. As a
negative control, the genomic region of mir-278 was not
enriched in the FOXO ChIP (Figure 6E, white bars). Together,
these data indicate that expression of dDORFENLL is inhibited
by insulin signaling as a direct target of FOXO (Figure 6F),
and identify a molecular mechanism by which insulin signaling
inhibits ecdysone signaling in the fat body. Because dDOR is
involved in linking nutrient signaling to EcR signaling, we
tested whether dDOR mutants have impaired fitness upon
nutrient deprivation. Upon removal of food (but not water),
dDOR knockout animals died more rapidly than controls
(Figure S5B).
dDOR Forms a Feed-Forward Regulatory Loop
of Ecdysone Signaling
Insulin signaling in the fat body is inhibited by ecdysone
signaling [18, 21–23]. Activation of the ecdysone pathway
in vivo in the fat body causes a reduction in PI3K activity and
increased FOXO activity [18, 23]. Because our data indicate
that dDORFENLL is a direct FOXO target, this raises the possi-
bility that dDORFENLL is part of a feed-forward mechanism
whereby ecdysone, via insulin signaling, amplifies expression
of components required for its own signaling (Figure 6F). We
tested this possibility by treating explanted fat bodies in thepresence or absence of 20E for 4 hr. In the presence of 20E,
expression of the two FOXO targets 4E-BP and dDORFENLL
both increased, as assayed by quantitative RT-PCR
(**t test < 0.01, Figures 6C and 6C0). As expected, in fat bodies
explanted from FOXO mutants, treatment with 20E no longer
increased expression of either dDORFENLL or 4E-BP (Figures
6D and 6D0). Consistent with this notion, expression of
dDORFENLL also increases in vivo when third-instar larvae
transition from feeding to wandering as a consequence of an
ecdysone pulse (***t test < 0.0001, Figure 6G). These data indi-
cate that ecdysone signaling increases expression of
dDORFENLL in a FOXO-dependent manner. Because
dDORFENLL is required for efficient ecdysone signaling, this
forms a feed-forward regulatory loop (Figure 6F).
Discussion
We discover here a novel coactivator of the ecdysone
receptor, dDOR, which plays an important role during meta-
morphosis. Clearly not all EcR functions are impaired in DOR
mutants. For instance, we see very little lethality during larval
stages of development, indicating that larval molts are occur-
ring properly. It is possible that different EcR coactivators are
important for different aspects of EcR signaling, for instance
with rigor mortis playing an important role in the regulation of
larval molts [16]. Alternatively, because induction of EcR target
genes is reduced but not completely eliminated in dDOR
knockout animals, this could reflect the differential sensitivity
of various biological processes to the degree of EcR activa-
tion. Future workmay shedmore light on this issue. Interesting
in this context is that we were able to rescue the lethality of
DOR knockouts by feeding 20E. This suggests that either
DOR knockouts also have low ecdysone titers due to impaired
expression of E75A, which is involved in an ecdysone feed-
forward production pathway [38], or because the elevated
ecdysone titers achieved by supplying exogenous 20E allow
other coactivators to compensate for DOR loss of function.
This work identifies a new link between ecdysone signaling
and insulin signaling. It was previously known that ecdysone
signaling inhibits insulin signaling in the fat body [18, 21–23].
We show here that, conversely, insulin signaling also inhibits
ecdysone signaling. When insulin signaling is high, FOXO acti-
vation is low and dDOR expression is low. Conversely, when
insulin signaling drops, this allows FOXO to become active,
resulting in elevated levels of dDOR expression and maximal
activation of EcR target genes. In sum, we find that there is
a mutual antagonistic relationship between insulin signaling
and ecdysone signaling in the fat body, possibly creating a
system with two equilibrium states—high ecdysone/low
insulin and low ecdysone/high insulin. This makes biological
sense because insulin plays an anabolic role in the fat body,
whereas ecdysone plays a catabolic role, encouraging lipid
mobilization and autophagy. By identifying dDOR as a direct
FOXO target, we shed light on the molecular mechanism by
which part of this antagonistic relationship is achieved.
A second consequence of the regulation of dDOR by FOXO
is the creation of a feed-forward regulatory mechanism. When
ecdysone signaling is activated, it inhibits insulin signaling and
activates FOXO, causing increased expression of dDOR. This
results in potentiation of the ecdysone signal. This type of
mechanism may be important for the dramatic activation of
the ecdysone pathway at the end of larval development.
Indeed, ecdysone signaling has several autoregulatory posi-
tive feedback loops, including EcR-dependent transcription
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1807of the EcR gene and downregulation of a microRNA, miR-14,
which inhibits EcR expression [39].
DORwas first identified as a genewhose expression is aber-
rant in Zucker diabetic rats [4]. Until DOR knockout mice are
analyzed, it is possible that this aberrant regulation is either
a cause or a consequence of the diabetes. Because dDOR
knockout flies have reduced triglyceride and elevated
glycogen stores (Figures 5A and 5B), it is tempting to specu-
late that aberrant DOR expression in mammals might actually
cause metabolic defects and not simply be a consequence of
them. AlthoughDOR expressionwas downregulated inmuscle
of diabetic rats [4], we found a 2-fold increase in hDOR
expression in adipose tissue of type 2 diabetic patients (A.Z.,
unpublished data). This indicates that regulation of DOR
expression—and hence the effect on metabolism—in condi-
tions of metabolic disease in mammals is likely to be tissue
specific and complex. The reduction in triglycerides in dDOR
knockout flies is also interesting in light of the antagonistic
relationship between ecdysone signaling and insulin signaling
in the fly. Previous work has shown that flies with systemically
reduced insulin signaling have elevated triglyceride levels
[40, 41]. Therefore, the leanness of dDOR knockouts would
be consistent with increased systemic insulin signaling in
dDOR knockout animals.
Intriguingly, dDOR shares a number of features with its
mammalian homolog. Like hDOR, dDOR functions as a nuclear
hormone coactivator. Whereas hDOR binds TRa1, dDOR binds
EcR. TRa1 and EcR are similar in that they both form heterodi-
meric complexes with RXR/USP. In fact, EcR can form
a functional complex with the human USP homolog RXR in
mammalian cells [9, 10]. Furthermore, EcR and TRa1 both
play catabolic roles in some contexts. For instance, ecdysone
signaling induces autophagy and lipid mobilization in the fat
body and programmed cell death in salivary glands during
metamorphosis [23, 42]. Likewise, thyroid hormones increase
basal metabolic rates, induce fat mobilization, and enhance
fatty acid oxidation [43]. A second similarity between dDOR
and hDOR is that both are transcriptionally regulated by nutri-
tional inputs. DOR expression is misregulated in diabetic rats,
whereas dDOR expression changes depending onwhether the
animals are feeding or fasting. Because we find that regulation
of dDOR expression is insulin and FOXO dependent, this rai-
ses the possibility that the transcriptional effect onDOR in dia-
betic rats may also be insulin dependent. A third similarity is
that both hDOR and dDOR have two separable functions—
as a nuclear hormone receptor coactivator, and as a regulator
of autophagy (this work and [5, 6]). This makes particular
biological sense within the context of the fat body, where
ecdysone signaling induces autophagy during metamor-
phosis. Therefore, the dual functions of dDOR work in parallel,
both by potentiating ecdysone signaling and by interacting
with the autophagy proteins Atg8a/b.
In sum, this work discovers dDOR as a novel EcR coactiva-
tor required during fly metamorphosis. Furthermore, it iden-
tifies dDOR as a novel component of a gene regulatory
network integrating ecdysone and insulin signaling to regulate
fly development and metabolism.Experimental Procedures
Expression Constructs, Fly Lines, and qPCR
All oligos used for cloning, for quantitative RT-PCR, and for qPCR are listed
in the Supplemental Experimental Procedures, as is a detailed description
of plasmid constructions (overexpression and knockout constructs).Pal1sx-188-cc-Luc and s-188-cc-RLuc plasmids with the EcRE-luciferase
construct and Renilla control were obtained from the DGRC collection. Flies
containing tubulin-Gal4, hs-GAL4, hs-EcR-B2, UAS-EcRW650A, and ecd[1]
were from the Bloomington Stock Center (BSD); FOXO21 and FOXO25
were previously described in [36].
Antibodies and Immunoprecipitation
Anti-FLAG (Sigma, F1804), anti-HA (Roche, 11867423001), and anti-EcR
(DSHB, DDA2.7) were used. Anti-dDOR was raised in guinea pigs against
the full-length dDORlong protein expressed in E. coli. Protein G-agarose
was from Roche.
Metabolic Analyses
Flies were grown at a controlled density of 50 larvae per vial on food consist-
ing of 10 liters water, 80 g agar, 800 g corn powder, 100 g soya powder, 180 g
dry yeast, 800 g malt extract, 220 g syrup, 62.5 ml propionic acid, 6.25 ml
phosphoric acid, and 24 g nipagin. Lipids, glycogen, and trehalose were
quantified in 1-day-old males as described in the Supplemental Experi-
mental Procedures.
Staging of Animals for qRT-PCR on Ecdysone Response Genes
L1 larvae hatchingwithin a tight 4 hr timewindowwere picked and seeded in
vials containing food (as above) supplemented with 0.05% bromophenol
blue at a density of 50 per vial and grown at 25C. This procedure was
repeated on multiple subsequent days. ‘‘Feeding’’ L3 animals are animals
24 hr prior to pupation (based on the pupation behavior of siblings). Animals
18 hr, 8 hr, and 4 hr prior to pupation were based on clearance of blue food
from the guts as described [44]. ‘‘Wandering’’ L3 animals are animals 0 to
6 hr prior to pupation.
Ecdysone Treatment of Fat Body Explants
Fat bodies were dissected fromwandering third-instar larvae and incubated
for 4 hr in Grace’s insectmedium (Sigma) in the presence or absence of 1 mM
20-hydroxyecdysone (Sigma) as indicated. RNA was then extracted with
Trizol as previously described [32].
Supplemental Information
Supplemental Information includes Supplemental Experimental Procedures
and five figures and can be foundwith this article online at doi:10.1016/j.cub.
2010.08.055.
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